Skip to main content
Download PDF

Correction to: Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis

Acta Neuropathologica Communications volume 10, Article number: 104 (2022) Cite this article

The Original Article was published on 15 June 2022

Correction to: Acta Neuropathologica Communications (2022) 10:87 https://doi.org/10.1186/s40478-022-01391-y

Following publication of the original article [1], two missing sections were identified in the back matter of the article: the ‘Author contributions’ section and the ‘Competing interests’ section.

The statement in the ‘Author contributions’ section should read: GMM performed all EAE experiments and collected and analyzed IHC, IF, and EM data for all experiments, produced all figures from EAE data, and wrote manuscript draft. KSE assisted with initial EAE experiment and analyzed GFAP and Iba1 data in mouse thalamus. LMW and MKC assisted with cell counting and data analysis for CD3 and NeuN staining. RS, JCB, and BAA performed OCT imaging and analysis for rodent studies and contributed to the final revisions of the manuscript. MY and NSP recorded and analyzed VEPs from rodent studies and contributed to final revisions of the manuscript. RB, DO, and KN provided MS patient data as well as MRI imaging analysis and contributed to final manuscript revision. KRM performed analyses of human OCT, correlative analysis with MRI and neuroperformance measures, and contributed to conceptualization of research and writing of final manuscript. TMD conceptualized the research, oversaw all research, and wrote, revised, and edited the final manuscript. All authors read and approved the final manuscript.

The statement in the ‘Competing interests’ section should read: Dr. Robert Bermel discloses consultation for Astra Zeneca, Biogen, EMD Serono, Genzyme/Sanofi, Genentech/Roche, LabCorp, Novartis, TG Therapeutics, and VielaBio. Dr. Robert Bermel also discloses research support from Biogen, Genentech, and Novartis, and shares rights to intellectual property underlying the Multiple Sclerosis Performance Test, currently licensed to Qr8 Health and Biogen. Dr. Daniel Ontaneda discloses research support from Genentech, Genzyme, and Novartis and consulting fees from Biogen Idec, Genentech/Roche, Genzyme, Janssen, Novartis, and Merck. Dr. Kunio Nakamura discloses personal compensation for licensing from Biogen and research support from Genzyme and Biogen. All other authors declare no competing interests.

The original article [1] has been updated.

Reference

  1. Mey GM et al (2022) Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis. Acta Neuropathol Commun 10:87. https://doi.org/10.1186/s40478-022-01391-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Kirsten S. Evonuk

    Present address: Hooke Laboratories, Inc, Lawrence, MA, USA

Authors and Affiliations

  1. Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, and Case Western Reserve University, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Gabrielle M. Mey, Kirsten S. Evonuk, McKenzie K. Chappell, Laura M. Wolfe, Kedar R. Mahajan & Tara M. DeSilva

  2. Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    Rupesh Singh, Julia C. Batoki, Minzhong Yu, Neal S. Peachey & Bela Anand‑Apte

  3. Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA

    Minzhong Yu, Neal S. Peachey & Bela Anand‑Apte

  4. Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA

    Neal S. Peachey

  5. Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    Robert Bermel, Daniel Ontaneda & Kedar R. Mahajan

  6. Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    Kunio Nakamura

Authors
  1. Gabrielle M. Mey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirsten S. Evonuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. McKenzie K. Chappell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura M. Wolfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rupesh Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Julia C. Batoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Minzhong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Neal S. Peachey
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bela Anand‑Apte
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Robert Bermel
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Daniel Ontaneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kunio Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Kedar R. Mahajan
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Tara M. DeSilva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tara M. DeSilva.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mey, G.M., Evonuk, K.S., Chappell, M.K. et al. Correction to: Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis. acta neuropathol commun 10, 104 (2022). https://doi.org/10.1186/s40478-022-01405-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40478-022-01405-9

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us